Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>SINO BIOPHARM Annual NP RMB3.5B, Up 50.1%; Final DPS HKD4 Cents
Recommend 27 Positive 40 Negative 19 |
||||
|
||||
|
SINO BIOPHARM (01177.HK) announced its full-year results for the period ending December 31, 2024. Revenue reached RMB28.866 billion, up 10.2% YoY. It recorded a net profit of RMB3.5 billion, up 50.1% YoY, with EPS at RMB19.13 cents. The company declared a final DPS of HKD4 cents, compared to HKD3 cents in the same period of the previous year. Combined with the interim dividend of HKD3 cents already distributed, the total DPS for the year amounted to HKD7 cents. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
